Stay updated on BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.

Latest updates to the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating access to the study record is blocked. This reflects an access/availability change rather than a substantive update to the page content.SummaryDifference17%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the study page, reflecting the latest documentation version. This change does not alter study details or results.SummaryDifference0.0%

- Check41 days agoChange DetectedA new entry '2017 ( U.S. NIH Grant/Contract )' was added under the study's other identifiers, indicating NIH funding for the trial.SummaryDifference0.0%

- Check55 days agoChange DetectedA new revision label Revision: v3.6.5 is shown on the page, and the Investigator Inquiry Form along with the previous Revision: v3.6.4 label have been removed.SummaryDifference0.1%

- Check69 days agoChange DetectedThe Study Details page shows a revision update from v3.6.3 to v3.6.4, indicating an administrative update to the page rather than changes to study data.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page revision tag changed from v3.6.2 to v3.6.3, indicating a small update to the page or its accompanying documents.SummaryDifference0.0%

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.